1. Home
  2. NBTX vs HAWK Comparison

NBTX vs HAWK Comparison

Compare NBTX & HAWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nanobiotix S.A.

NBTX

Nanobiotix S.A.

HOLD

Current Price

$38.05

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Logo HawkEye 360 Inc. Common Stock

HAWK

HawkEye 360 Inc. Common Stock

N/A

Current Price

$22.77

Market Cap

2.0B

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
NBTX
HAWK
Founded
2003
N/A
Country
France
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.0B
IPO Year
2018
2026

Fundamental Metrics

Financial Performance
Metric
NBTX
HAWK
Price
$38.05
$22.77
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$36.00
N/A
AVG Volume (30 Days)
119.2K
926.1K
Earning Date
03-31-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$58.17
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.03
$17.02
52 Week High
$57.14
$25.71

Technical Indicators

Market Signals
Indicator
NBTX
HAWK
Relative Strength Index (RSI) 49.41 52.45
Support Level $34.83 $18.75
Resistance Level $41.99 $25.71
Average True Range (ATR) 1.99 1.55
MACD -0.09 0.22
Stochastic Oscillator 51.22 60.91

Price Performance

Historical Comparison
NBTX
HAWK

About NBTX Nanobiotix S.A.

Nanobiotix SA is a late-stage clinical biotechnology company focused on re-inventing medicine by building new therapies atom by atom, developing widely applicable, first-in-class, physics-based nanotherapeutics to transform treatment outcomes and expand life for millions of patients. The objective of this physics-based approach is to allow nanoparticles to be combined with other drugs or therapeutic modalities and to integrate seamlessly into clinical practice without adding burden for the patient, healthcare provider, or healthcare system. It has three platforms Nanoradioenhancer platform: Nanoprimer platform: and Neurological disease platform. It has one segment, which is the research and development of product candidates that use proprietary nanotechnology to transform cancer treatment.

About HAWK HawkEye 360 Inc. Common Stock

Hawkeye 360 Inc operates in the signals intelligence (SIGINT) and defense technology sector. It provides end-to-end signals intelligence solutions integrated into national security systems for the United States and allied customers. Its offerings include radio frequency data and related insights to support defense operations. The company is involved across the value chain, including satellite design and manufacturing, data collection, and data processing and analysis. It generates revenue prominently from fixed price contract arrangements for RF signal mapping products that are used to analyze and track radio waves.

Share on Social Networks: